Mometasone/glycopyrronium/indacaterol

National NHS prescribing (Prescription Cost Analysis) · Corticosteroids (respiratory)

Data updated March 2026

Mometasone/glycopyrronium/indacaterol was ranked 734th of 1,794 medicines by items in March 2026, with 2,451 items, up 12.4% on a year earlier.

2,451items

Dispensed in March 2026

NHSBSA Prescription Cost Analysis

£124,734

Net ingredient cost · March 2026

NHSBSA PCA

28,417items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Mometasone/glycopyrronium/indacaterol: national items dispensed by month

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV

Embed this chart

<iframe src="https://pharmainsight.co.uk/embed/medicines/mometasoneglycopyrroniumindacaterol-0302000w0" width="100%" height="280" style="border:0" loading="lazy" title="Mometasone/glycopyrronium/indacaterol: NHS prescribing in England — PharmaInsight"></iframe>

Presentations of Mometasone/glycopyrronium/indacaterol, March 2026
Presentation	Items	Net ingredient cost
Enerzair Breezhaler 114microg / 46microg / 136microg/dose	2,451	£124,734

Compare Mometasone/glycopyrronium/indacaterol with

Other medicines in the same BNF section, by prescribing volume.

Top presentations, March 2026

Compare Mometasone/glycopyrronium/indacaterol with